Q: Given a passage with a question and an answer to that question, classify if the answer actually answers the question into 'yes' or 'no'. Output 'yes' if the answer answers the question and output 'no' if the answer does not answer the question.
Question: Does the experimental neuroprotectant leukaemia inhibitory factor ( LIF ) compromise antitumour activity of paclitaxel , cisplatin and carboplatin?
Answer: These results suggest that LIF may be safely used in human trials as a neuroprotectant for patients receiving cisplatin, paclitaxel and carboplatin without concern for impairment of antitumour effect.
A:
no